JPMORGAN CHASE & CO - ALLSCRIPTS HEALTHCARE SOLUTN ownership

ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 255 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q3 2018. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of ALLSCRIPTS HEALTHCARE SOLUTN
ValueSharesWeighting
Q3 2023$16,320,537
+0.2%
1,242,050
-3.9%
0.00%0.0%
Q2 2023$16,281,833
+22.5%
1,292,209
+26.9%
0.00%0.0%
Q1 2023$13,285,900
+41662.5%
1,018,156
-43.5%
0.00%
-50.0%
Q4 2022$31,813
-99.9%
1,803,496
-4.1%
0.00%0.0%
Q3 2022$28,635,000
-16.6%
1,880,193
-18.8%
0.00%
-20.0%
Q2 2022$34,336,000
-45.0%
2,315,274
-16.5%
0.01%
-37.5%
Q1 2022$62,419,000
-13.9%
2,771,775
-29.5%
0.01%0.0%
Q4 2021$72,530,000
+36.4%
3,931,208
-1.2%
0.01%
+14.3%
Q3 2021$53,187,000
-21.0%
3,978,142
+9.4%
0.01%
-12.5%
Q2 2021$67,310,000
+52.5%
3,636,410
+23.7%
0.01%
+33.3%
Q1 2021$44,136,000
+53.0%
2,939,398
+47.1%
0.01%
+50.0%
Q4 2020$28,855,000
+2.2%
1,998,250
-43.0%
0.00%
-20.0%
Q3 2020$28,246,000
+1.6%
3,504,541
-14.7%
0.01%0.0%
Q2 2020$27,813,000
-12.3%
4,108,309
-8.8%
0.01%
-28.6%
Q1 2020$31,726,000
-19.8%
4,506,471
+11.9%
0.01%0.0%
Q4 2019$39,535,000
-24.2%
4,028,031
-15.2%
0.01%
-30.0%
Q3 2019$52,132,000
+2.0%
4,747,957
+6.3%
0.01%0.0%
Q2 2019$51,131,000
+280.6%
4,465,650
+217.1%
0.01%
+233.3%
Q1 2019$13,435,000
-33.3%
1,408,320
-32.6%
0.00%
-40.0%
Q4 2018$20,146,000
-60.5%
2,089,749
-41.6%
0.01%
-50.0%
Q3 2018$50,974,000
+40.8%
3,577,112
+18.6%
0.01%
+42.9%
Q2 2018$36,192,000
+4.1%
3,015,883
+7.1%
0.01%0.0%
Q1 2018$34,775,000
-26.8%
2,815,770
-13.8%
0.01%
-30.0%
Q4 2017$47,528,000
+94.5%
3,266,476
+90.3%
0.01%
+100.0%
Q3 2017$24,438,000
-27.7%
1,716,227
-35.3%
0.01%
-37.5%
Q2 2017$33,824,000
+21.2%
2,650,782
+20.5%
0.01%
+33.3%
Q1 2017$27,897,000
+108.0%
2,200,148
+67.5%
0.01%
+100.0%
Q4 2016$13,411,000
-48.8%
1,313,488
-34.0%
0.00%
-50.0%
Q3 2016$26,203,000
+3.5%
1,989,575
-0.2%
0.01%0.0%
Q2 2016$25,308,000
+5.9%
1,992,756
+10.2%
0.01%0.0%
Q1 2016$23,888,000
-15.9%
1,808,313
-2.1%
0.01%
-14.3%
Q4 2015$28,397,000
+26.0%
1,846,350
+1.6%
0.01%
+16.7%
Q3 2015$22,539,000
-81.0%
1,817,660
-79.0%
0.01%
-78.6%
Q2 2015$118,369,000
+12.7%
8,652,658
-1.4%
0.03%
+16.7%
Q1 2015$105,004,000
-16.7%
8,779,533
-11.1%
0.02%
-17.2%
Q4 2014$126,053,000
+42.1%
9,871,052
+49.3%
0.03%
+38.1%
Q3 2014$88,720,000
+48.9%
6,613,493
+78.2%
0.02%
+40.0%
Q2 2014$59,569,000
-1.4%
3,711,490
+10.7%
0.02%
-11.8%
Q1 2014$60,429,000
+19.5%
3,351,508
+2.5%
0.02%
+21.4%
Q4 2013$50,554,000
+9.0%
3,269,975
+4.8%
0.01%0.0%
Q3 2013$46,389,000
+3088.2%
3,119,577
+2676.3%
0.01%
Q2 2013$1,455,000112,3660.00%
Other shareholders
ALLSCRIPTS HEALTHCARE SOLUTN shareholders Q3 2018
NameSharesValueWeighting ↓
Tamarack Advisers, LP 1,500,000$21,593,0004.50%
KESTREL INVESTMENT MANAGEMENT CORP 445,500$6,433,0003.14%
Adirondack Research & Management Inc. 155,088$2,239,0003.06%
SHAPIRO CAPITAL MANAGEMENT LLC 9,398,617$135,716,029,0002.92%
Waterfront Wealth Inc. 136,976$1,978,0001.40%
Smith, Graham & Co., Investment Advisors, LP 1,008,283$14,560,0001.34%
S&T BANK/PA 475,184$6,862,0001.23%
PARADIGM CAPITAL MANAGEMENT INC/NY 1,132,500$16,354,0000.98%
HENNESSY ADVISORS INC 1,024,100$14,788,0000.95%
BEACONLIGHT CAPITAL, LLC 208,546$3,011,0000.91%
View complete list of ALLSCRIPTS HEALTHCARE SOLUTN shareholders